SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-037331
Filing Date
2020-11-16
Accepted
2020-11-16 16:00:50
Documents
40
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_wizepharma.htm 10-Q 434104
2 FORM OF AMENDMENT NO. 1, DATED AS OF OCTOBER 28, 2020, TO THE SECURITIES PURCHAS f10q0920ex10-1_wizepha.htm EX-10.1 16632
3 CERTIFICATION f10q0920ex31-1_wizepha.htm EX-31.1 8472
4 CERTIFICATION f10q0920ex31-2_wizepha.htm EX-31.2 9137
5 CERTIFICATION f10q0920ex32-1_wizepha.htm EX-32.1 5827
6 CERTIFICATION f10q0920ex32-2_wizepha.htm EX-32.2 5890
  Complete submission text file 0001213900-20-037331.txt   2176051

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE wizp-20200930.xml EX-101.INS 359742
8 XBRL SCHEMA FILE wizp-20200930.xsd EX-101.SCH 36045
9 XBRL CALCULATION FILE wizp-20200930_cal.xml EX-101.CAL 31618
10 XBRL DEFINITION FILE wizp-20200930_def.xml EX-101.DEF 67869
11 XBRL LABEL FILE wizp-20200930_lab.xml EX-101.LAB 186066
12 XBRL PRESENTATION FILE wizp-20200930_pre.xml EX-101.PRE 125563
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52545 | Film No.: 201316543
SIC: 2834 Pharmaceutical Preparations